CN1112925A - 咪唑吡啶衍生物及其制备方法 - Google Patents
咪唑吡啶衍生物及其制备方法 Download PDFInfo
- Publication number
- CN1112925A CN1112925A CN95103763A CN95103763A CN1112925A CN 1112925 A CN1112925 A CN 1112925A CN 95103763 A CN95103763 A CN 95103763A CN 95103763 A CN95103763 A CN 95103763A CN 1112925 A CN1112925 A CN 1112925A
- Authority
- CN
- China
- Prior art keywords
- compound
- group
- pharmaceutically acceptable
- acceptable salt
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP79079/1994 | 1994-04-19 | ||
| JP7907994 | 1994-04-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1112925A true CN1112925A (zh) | 1995-12-06 |
Family
ID=13679895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95103763A Pending CN1112925A (zh) | 1994-04-19 | 1995-04-19 | 咪唑吡啶衍生物及其制备方法 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0682023B1 (enExample) |
| KR (1) | KR950032200A (enExample) |
| CN (1) | CN1112925A (enExample) |
| AT (1) | ATE148885T1 (enExample) |
| AU (1) | AU679616B2 (enExample) |
| BR (1) | BR9501713A (enExample) |
| CA (1) | CA2146802A1 (enExample) |
| DE (1) | DE69500156T2 (enExample) |
| DK (1) | DK0682023T3 (enExample) |
| ES (1) | ES2100755T3 (enExample) |
| FI (1) | FI951828A7 (enExample) |
| GR (1) | GR3022559T3 (enExample) |
| IL (1) | IL113309A (enExample) |
| TW (1) | TW300896B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012031024A1 (en) * | 2010-08-31 | 2012-03-08 | Vanderbilt University | Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mglur5 receptors |
| GB201321749D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL95975A (en) * | 1989-10-24 | 1997-06-10 | Takeda Chemical Industries Ltd | N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them |
| EP0531874A1 (en) * | 1991-09-10 | 1993-03-17 | Tanabe Seiyaku Co., Ltd. | Imidazopyridine derivatives and process for preparation thereof |
| JP2564784B2 (ja) * | 1991-09-10 | 1996-12-18 | 田辺製薬株式会社 | イミダゾピリジン誘導体及びその製法 |
| TW284688B (enExample) * | 1991-11-20 | 1996-09-01 | Takeda Pharm Industry Co Ltd |
-
1995
- 1995-04-05 AU AU16257/95A patent/AU679616B2/en not_active Ceased
- 1995-04-10 IL IL113309A patent/IL113309A/en not_active IP Right Cessation
- 1995-04-11 CA CA002146802A patent/CA2146802A1/en not_active Abandoned
- 1995-04-17 TW TW084103739A patent/TW300896B/zh active
- 1995-04-18 DE DE69500156T patent/DE69500156T2/de not_active Expired - Fee Related
- 1995-04-18 DK DK95105771.0T patent/DK0682023T3/da active
- 1995-04-18 EP EP95105771A patent/EP0682023B1/en not_active Expired - Lifetime
- 1995-04-18 ES ES95105771T patent/ES2100755T3/es not_active Expired - Lifetime
- 1995-04-18 BR BR9501713A patent/BR9501713A/pt not_active Application Discontinuation
- 1995-04-18 AT AT95105771T patent/ATE148885T1/de active
- 1995-04-18 FI FI951828A patent/FI951828A7/fi unknown
- 1995-04-19 CN CN95103763A patent/CN1112925A/zh active Pending
- 1995-04-19 KR KR1019950009266A patent/KR950032200A/ko not_active Withdrawn
-
1997
- 1997-02-13 GR GR970400048T patent/GR3022559T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0682023T3 (da) | 1997-03-17 |
| IL113309A (en) | 1998-03-10 |
| KR950032200A (ko) | 1995-12-20 |
| FI951828L (fi) | 1995-10-20 |
| CA2146802A1 (en) | 1995-10-20 |
| DE69500156T2 (de) | 1997-06-19 |
| ES2100755T3 (es) | 1997-06-16 |
| AU1625795A (en) | 1995-10-26 |
| EP0682023B1 (en) | 1997-02-12 |
| FI951828A0 (fi) | 1995-04-18 |
| GR3022559T3 (en) | 1997-05-31 |
| IL113309A0 (en) | 1995-07-31 |
| FI951828A7 (fi) | 1995-10-20 |
| TW300896B (enExample) | 1997-03-21 |
| BR9501713A (pt) | 1995-11-14 |
| ATE148885T1 (de) | 1997-02-15 |
| AU679616B2 (en) | 1997-07-03 |
| EP0682023A1 (en) | 1995-11-15 |
| DE69500156D1 (de) | 1997-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3527573B9 (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| JP5685082B2 (ja) | オルメサルタンメドキソミルの調製または精製の方法 | |
| CN1105109C (zh) | 氯代嘧啶中间体 | |
| CN1070489C (zh) | 取代的亚砜类化合物的合成方法 | |
| EP0389352B1 (fr) | Dérivés fluoro-4 benzoiques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent | |
| CN1069098C (zh) | 新的咪唑衍生物及其制备方法 | |
| CN87107928A (zh) | 利拜卡霉素类似物 | |
| CN101048376A (zh) | 二氢吲哚化合物及其生产方法 | |
| CN1561341A (zh) | 用氢氧化钙水解[R(R*,R*)]-2-(4-氟代苯基)-β,δ-二羟基-5-(1-甲基乙基)-3-苯基-4-[(苯基氨基)羰基]-1H-吡咯-1-庚酸酯 | |
| EP2269990A1 (en) | Heterocyclic compound | |
| CN1374952A (zh) | 苯并咪唑酮衍生物及其作为磷酸二酯酶抑制剂的用途 | |
| CN1252072C (zh) | 4,6-二氨基嘧啶并[5,4-d]嘧啶的制备方法 | |
| CN1771234A (zh) | 吡咯并三嗪激酶抑制剂的制备方法 | |
| CN1131864C (zh) | 吗啉衍生物的化学合成方法 | |
| KR19990076616A (ko) | 2,7-치환된 옥타하이드로-피롤로[1,2-에이]피라진 유도체 | |
| CN1128148C (zh) | (1H)-苯并[c]喹嗪-3-酮衍生物的合成方法 | |
| CN100344615C (zh) | 制备N-(吡咯并[2,3-d]嘧啶-5-基)酰基谷氨酸衍生物的方法及中间体 | |
| EP0136198A1 (fr) | Dérivés de triazolo pyrimidine, leur procédé de préparation et leur application thérapeutique en tant que toni-cardiaques | |
| CN1112925A (zh) | 咪唑吡啶衍生物及其制备方法 | |
| MC1184A1 (fr) | Derives d'oxadiazolopyrimidine | |
| CN1374947A (zh) | 制备鼻病毒蛋白酶抑制剂的合成路线以及关键的中间体 | |
| CN1014992B (zh) | 喹唑啉二酮和吡啶并嘧啶二酮的制备方法 | |
| CN1065529C (zh) | 4-喹啉酮衍生物及其盐 | |
| CN1441802A (zh) | 用以治疗阳痿的吡唑并嘧啶酮衍生物的制备方法 | |
| CN1269814C (zh) | 哒嗪酮抗糖尿病药的制备方法和中间体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |